DK0710111T3 - Hormonalt middel til behandling af acne og dets anvendelse - Google Patents

Hormonalt middel til behandling af acne og dets anvendelse

Info

Publication number
DK0710111T3
DK0710111T3 DK94916880T DK94916880T DK0710111T3 DK 0710111 T3 DK0710111 T3 DK 0710111T3 DK 94916880 T DK94916880 T DK 94916880T DK 94916880 T DK94916880 T DK 94916880T DK 0710111 T3 DK0710111 T3 DK 0710111T3
Authority
DK
Denmark
Prior art keywords
hormonal
hormone
daily units
component
hormone component
Prior art date
Application number
DK94916880T
Other languages
Danish (da)
English (en)
Inventor
Marika Dr Med Ehrlich
Herbert Prof Dr Kuhl
Original Assignee
Marika Dr Med Ehrlich
Herbert Prof Dr Kuhl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0710111(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Marika Dr Med Ehrlich, Herbert Prof Dr Kuhl filed Critical Marika Dr Med Ehrlich
Application granted granted Critical
Publication of DK0710111T3 publication Critical patent/DK0710111T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DK94916880T 1993-07-01 1994-06-03 Hormonalt middel til behandling af acne og dets anvendelse DK0710111T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4321957A DE4321957C2 (de) 1993-07-01 1993-07-01 Verwendung eines hormonalen Mittels zur Therapie der Akne
PCT/DE1994/000629 WO1995001180A1 (de) 1993-07-01 1994-06-03 Hormonales mittel zur therapie der akne und dessen verwendung

Publications (1)

Publication Number Publication Date
DK0710111T3 true DK0710111T3 (da) 2001-12-10

Family

ID=6491735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916880T DK0710111T3 (da) 1993-07-01 1994-06-03 Hormonalt middel til behandling af acne og dets anvendelse

Country Status (14)

Country Link
EP (1) EP0710111B1 (ja)
JP (1) JPH09500112A (ja)
AT (1) ATE205716T1 (ja)
AU (1) AU695894B2 (ja)
BR (1) BR9407340A (ja)
CA (1) CA2166121A1 (ja)
DE (2) DE4321957C2 (ja)
DK (1) DK0710111T3 (ja)
ES (1) ES2164103T3 (ja)
HU (1) HUT73234A (ja)
NO (1) NO308586B1 (ja)
PT (1) PT710111E (ja)
UA (1) UA43337C2 (ja)
WO (1) WO1995001180A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534209A1 (de) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonales Mittel zur Behandlung der Haut
AU1690399A (en) * 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Neovascularization inhibitor containing dienogest as the active ingredient
DE102004026671A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026670A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102006003509A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Kontrazeptivum
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU565915B2 (en) * 1982-12-31 1987-10-01 Mortimer, C.H. Pharmaceutical composition of antibiotic and anti- androgen
DE3442857A1 (de) * 1984-11-22 1986-05-22 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur behandlung von androgenisierungserscheinungen bei der frau
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4104385C1 (ja) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
AU695894B2 (en) 1998-08-27
NO955347D0 (no) 1995-12-29
DE4321957A1 (de) 1995-01-12
BR9407340A (pt) 1996-10-08
HUT73234A (en) 1996-07-29
DE4321957C2 (de) 1995-09-28
DE59409869D1 (de) 2001-10-25
ES2164103T3 (es) 2002-02-16
EP0710111A1 (de) 1996-05-08
WO1995001180A1 (de) 1995-01-12
HU9503770D0 (en) 1996-02-28
ATE205716T1 (de) 2001-10-15
PT710111E (pt) 2002-02-28
CA2166121A1 (en) 1995-01-12
JPH09500112A (ja) 1997-01-07
NO308586B1 (no) 2000-10-02
AU6840894A (en) 1995-01-24
UA43337C2 (uk) 2001-12-17
EP0710111B1 (de) 2001-09-19
NO955347L (no) 1995-12-29

Similar Documents

Publication Publication Date Title
AU1255002A (en) Delayed-release pharmaceutical formulations
ATE296612T1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
DE69432752D1 (de) Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält
ES2140658T3 (es) Sistemas terapeuticos transdermicos que contienen esteroides sexuales.
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
BR9408513A (pt) Agente e método para a contracepçÃo hormonal e/ou para o tratamento de acne
HUP0100801A2 (hu) Metformin és fibrát kombinációját tartalmazó gyógyászati készítmények és ezek alkalmazása kórosan magas vércukorszint csökkentését célzó gyógyszerek előállítására
DK0705244T3 (da) Nitrato-aminosyredisulfid til behandling af sygdomme i det cardiovaskulære system
DE69101080D1 (de) Diätfaser, Verfahren und physiologische aktive Zusammensetzung, die diese als aktives Ingredient enhält.
IL112111A0 (en) Peptide derivatives and pharmaceutical compositions containing them
ATE279919T1 (de) Agmatin für die behandlung neuropathischer schmerzen
MY106938A (en) Method of treating premature ejaculation using sertraline
DK0668755T3 (da) Frembringelsesanorning, der har indkapslede excipienser
ATE171873T1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DK0663835T3 (da) Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
DK0710111T3 (da) Hormonalt middel til behandling af acne og dets anvendelse
ES2139081T3 (es) Composiciones farmaceuticas que contienen la hormona humana del crecimiento.
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
ES2100680T3 (es) Composicion para el tratamiento del cabello.
TNSN96016A1 (fr) Utilisation de phenylcyclohexylcarboxamides
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
DE60122943D1 (de) Zusammensetzung enthaltend oestrogen oder andere hormone mit ascorbat, lysin und prolin etc
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.
IT1269827B (it) Bicarbonato di lidocaina, suo uso farmaceutico e composizioni che lo contengono
GR1003059B (el) Βαλσαμινοελαιολαδο προιον αναγεννησης μαλλιων